Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Oncotarget
|
November 22, 2013
Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis
Alejandra Petrilli, Marga Bott, Cristina Fernández-Valle
Journal of Biophotonics
|
August 14, 2012
Measuring anisotropic cell motility on curved substrates
Kyle M Douglass, Nicklaus A Sparrow, Marga Bott, et al.
Molecular and Cellular Neurosciences
|
December 25, 2010
Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length
Courtney Thaxton, Marga Bott, Barbara Walker, et al.
Biology Open
|
December 6, 2012
Stability of the tumor suppressor merlin depends on its ability to bind paxillin LD3 and associate with β1 integrin and actin at the plasma membrane
Maria Elisa Manetti, Sandra Geden, Marga Bott, et al.
Molecular and Cellular Neurosciences
|
December 19, 2006
Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding
Courtney Thaxton, Jorge Lopera, Marga Bott, et al.
Biomaterials
|
April 14, 2009
Node of Ranvier formation on motoneurons in vitro
John W Rumsey, Mainak Das, Maria Stancescu, et al.
Glia
|
September 13, 2007
Serum and forskolin cooperate to promote G1 progression in Schwann cells by differentially regulating cyclin D1, cyclin E1, and p27Kip expression
Jared Iacovelli, Jorge Lopera, Marga Bott, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 13, 2012
The actin-severing protein cofilin is downstream of neuregulin signaling and is essential for Schwann cell myelination
Nicklaus Sparrow, Maria Elisa Manetti, Marga Bott, et al.
Experimental Neurology
|
June 14, 2015
Chronic inhibitory effect of riluzole on trophic factor production
Cassandra N Dennys, JeNay Armstrong, Mark Levy, et al.
American Journal of Translational Research
|
November 1, 2014
A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2
Alejandra M Petrilli, Marisa A Fuse, Mathew S Donnan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Oncotarget
|
November 22, 2013
Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis
Alejandra Petrilli, Marga Bott, Cristina Fernández-Valle
Journal of Biophotonics
|
August 14, 2012
Measuring anisotropic cell motility on curved substrates
Kyle M Douglass, Nicklaus A Sparrow, Marga Bott, et al.
Molecular and Cellular Neurosciences
|
December 25, 2010
Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length
Courtney Thaxton, Marga Bott, Barbara Walker, et al.
Biology Open
|
December 6, 2012
Stability of the tumor suppressor merlin depends on its ability to bind paxillin LD3 and associate with β1 integrin and actin at the plasma membrane
Maria Elisa Manetti, Sandra Geden, Marga Bott, et al.
Molecular and Cellular Neurosciences
|
December 19, 2006
Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding
Courtney Thaxton, Jorge Lopera, Marga Bott, et al.
Biomaterials
|
April 14, 2009
Node of Ranvier formation on motoneurons in vitro
John W Rumsey, Mainak Das, Maria Stancescu, et al.
Glia
|
September 13, 2007
Serum and forskolin cooperate to promote G1 progression in Schwann cells by differentially regulating cyclin D1, cyclin E1, and p27Kip expression
Jared Iacovelli, Jorge Lopera, Marga Bott, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 13, 2012
The actin-severing protein cofilin is downstream of neuregulin signaling and is essential for Schwann cell myelination
Nicklaus Sparrow, Maria Elisa Manetti, Marga Bott, et al.
Experimental Neurology
|
June 14, 2015
Chronic inhibitory effect of riluzole on trophic factor production
Cassandra N Dennys, JeNay Armstrong, Mark Levy, et al.
American Journal of Translational Research
|
November 1, 2014
A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2
Alejandra M Petrilli, Marisa A Fuse, Mathew S Donnan, et al.
Page
of 2